๐๐ฒ๐๐๐๐ฉ๐ญ๐ข๐ ๐๐๐ฎ๐ง๐๐ก๐๐ฌ ๐๐๐6 ๐ฐ๐ข๐ญ๐ก ๐๐ฏ๐ฒ: ๐๐๐ฏ๐๐ง๐๐๐ ๐๐ฆ๐๐ซ๐ญ...
๐
๐๐ ๐๐ฅ๐๐๐ซ๐ฌ ๐๐ฎ๐ฆ๐ข๐๐ก๐๐ซ๐โ๐ฌ ๐๐๐ฅ๐๐๐ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐จ๐ซ ๐๐ซ๐ฒ ๐๐๐
๐ LumiThera, Inc. has received FDA authorization for its Valedaยฎ Light Delivery System, marking a significant advancement in the treatment of dry age-related macular degeneration (AMD), a leading cause of vision loss in older adults. Valeda is the first authorized therapy for this condition and has shown to improve best corrected visual acuity over 24 months in clinical trials. The device utilises Photobiomodulation to potentially preserve retinal anatomy and reduce progression to geographic atrophy. This non-invasive treatment offers hope for early intervention in dry AMD patients.
